Ashana DC, Anesi GL, Liu VX, et al Equitably allocating resources during crises: racial differences in mortality prediction models. Am J Respir Crit Care Med. 2021 Jul;204(2):178–86. doi: 10.1164/rccm.202012-4383OC. PMID: 33751910. [PMC free article: PMC8759151] [PubMed: 33751910] [CrossRef]

Boley S, Sidebottom A, Vacquier M, et al Investigating racial disparities within an emergency department rapid-triage system. Am J Emerg Med. 2022 Jul;60:65–72. doi: 10.1016/j.ajem.2022.07.030. PMID: 35907271. [PubMed: 35907271] [CrossRef]

Carbunaru S, Nettey OS, Gogana P, et al A comparative effectiveness analysis of the PBCG vs PCPT risks calculators in a multiethnic cohort. BMC Urol. 2019 Nov;19(1):121. doi: 10.1186/s12894-019-0553-6. PMID: 31771578. [PMC free article: PMC6880480] [PubMed: 31771578] [CrossRef]

Han SS, Chow E, Ten Haaf K, et al Disparities of National Lung Cancer Screening Guidelines in the US population. J Natl Cancer Inst. 2020 Nov;112(11):1136–42. doi: 10.1093/jnci/djaa013. PMID: 32040195. [PMC free article: PMC7669226] [PubMed: 32040195] [CrossRef]

Metzger P, Allum L, Sullivan E, et al Racial and language disparities in pediatric emergency department triage. Pediatr Emerg Care. 2022 Feb;38(2):e556–e62. doi: 10.1097/PEC.0000000000002439. PMID: 34009885. [PubMed: 34009885] [CrossRef]

Miller WD, Han X, Peek ME, et al Accuracy of the sequential organ failure assessment score for in-hospital mortality by race and relevance to crisis standards of care. JAMA Netw Open. 2021 Jun;4(6):e2113891. doi: 10.1001/jamanetworkopen.2021.13891. PMID: 34143190. [PMC free article: PMC8214156] [PubMed: 34143190] [CrossRef]

Obermeyer Z, Powers B, Vogeli C, et al Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019 Oct;366(6464):447–53. doi: 10.1126/science.aax2342. PMID: 31649194. [PubMed: 31649194] [CrossRef]

Pasquinelli MM, Tammemägi MC, Kovitz KL, et al Brief report: risk prediction model versus United States Preventive Services Task Force 2020 draft lung cancer screening eligibility criteria-reducing race disparities. JTO Clin Res Rep. 2021 Mar;2(3):100137. doi: 10.1016/j.jtocrr.2020.100137. PMID: 34590000. [PMC free article: PMC8474224] [PubMed: 34590000] [CrossRef]

Presti JC, Alexeeff S, Horton B, et al Prospective validation of the Kaiser Permanente prostate cancer risk calculator in a contemporary, racially diverse, referral population. Urol Oncol. 2021 Nov;39(11):783.e11–.e19. doi: 10.1016/j.urolonc.2021.03.023. PMID: 33962850. [PubMed: 33962850] [CrossRef]

Riviello ED, Dechen T, O'Donoghue AL, et al Assessment of a crisis standards of care scoring system for resource prioritization and estimated excess mortality by race, ethnicity, and socially vulnerable area during a regional surge in COVID-19. JAMA Netw Open. 2022 Mar;5(3):e221744. doi: 10.1001/jamanetworkopen.2022.1744. PMID: 35289860. [PMC free article: PMC8924715] [PubMed: 35289860] [CrossRef]

Sarkar R, Martin C, Mattie H, et al Performance of intensive care unit severity scoring systems across different ethnicities in the USA: a retrospective observational study. Lancet Digital Health. 2021 Apr;3(4):e241–e9. doi: 10.1016/S2589-7500(21)00022-4. PMID: 33766288. [PMC free article: PMC8063502] [PubMed: 33766288] [CrossRef]

Snavely AC, Hendley N, Stopyra JP, et al Sex and race differences in safety and effectiveness of the HEART pathway accelerated diagnostic protocol for acute chest pain. Am Heart J. 2021 Feb;232:125–36. doi: 10.1016/j.ahj.2020.11.005. PMID: 33160945. [PMC free article: PMC7952042] [PubMed: 33160945] [CrossRef]

Thompson HM, Sharma B, Bhalla S, et al Bias and fairness assessment of a natural language processing opioid misuse classifier: detection and mitigation of electronic health record data disadvantages across racial subgroups. J Am Med Inform Assoc. 2021 Nov;28(11):2393–403. doi: 10.1093/jamia/ocab148. PMID: 34383925. [PMC free article: PMC8510285] [PubMed: 34383925] [CrossRef]

Wille KM, Harrington KF, Deandrade JA, et al Disparities in lung transplantation before and after introduction of the lung allocation score. J Heart Lung Transplant. 2013 Jul;32(7):684–92. doi: 10.1016/j.healun.2013.03.005. PMID: 23582477. [PMC free article: PMC3714222] [PubMed: 23582477] [CrossRef]

Williams RM, Li T, Luta G, et al Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 behavioral risk factor surveillance system data. Cancer. 2022 May;128(9):1812–9. doi: 10.1002/cncr.34098. PMID: 35201610. [PMC free article: PMC9007861] [PubMed: 35201610] [CrossRef]

Yoo RM, Dash D, Lu JH, et al Investigating real-world consequences of biases in commonly used clinical calculators. Am J Manag Care. 2023 Jan;29(1):e1–e7. doi: 10.37765/ajmc.2023.89306. PMID: 36716157. [PubMed: 36716157] [CrossRef]

Zhang X, Melanson TA, Plantinga LC, et al Racial/ethnic disparities in waitlisting for deceased donor kidney transplantation 1 year after implementation of the new national kidney allocation system. Am J Transplant. 2018 Aug;18(8):1936–46. doi: 10.1111/ajt.14748. PMID: 29603644. [PMC free article: PMC6105401] [PubMed: 29603644] [CrossRef]

Ahmed S, Nutt CT, Eneanya ND, et al Examining the potential impact of race multiplier utilization in estimated glomerular filtration rate calculation on African-American care outcomes. J Gen Intern Med. 2021 Feb;36(2):464–71. doi: 10.1007/s11606-020-06280-5. PMID: 33063202. [PMC free article: PMC7878608] [PubMed: 33063202] [CrossRef]

Baugh AD, Shiboski S, Hansel NN, et al Reconsidering the utility of race-specific lung function prediction equations. Am J Respir Crit Care Med. 2022 Apr;205(7):819–29. doi: 10.1164/rccm.202105-1246OC. PMID: 34913855. [PMC free article: PMC9836221] [PubMed: 34913855] [CrossRef]

Bundy JD, Mills KT, Anderson AH, et al Prediction of end-stage kidney disease using estimated glomerular filtration rate with and without race: a prospective cohort study. Ann Intern Med. 2022 Mar;175(3):305–13. doi: 10.7326/M21-2928. PMID: 35007146. [PMC free article: PMC9083829] [PubMed: 35007146] [CrossRef]

Casal MA, Ivy SP, Beumer JH, et al Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants. Lancet Oncol. 2021 Sep;22(9):1333–40. doi: 10.1016/S1470-2045(21)00377-6. PMID: 34399096. [PMC free article: PMC8425175] [PubMed: 34399096] [CrossRef]

Coresh J, Inker LA, Sang Y, et al Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study. Nephrol Dial Transplant. 2019 May;34(5):825–33. doi: 10.1093/ndt/gfy094. PMID: 29718360. [PMC free article: PMC6503300] [PubMed: 29718360] [CrossRef]

Diao JA, Wu GJ, Wang JK, et al National projections for clinical implications of race-free creatinine-based GFR estimating equations. J Am Soc Nephrol. 2023 Feb;34(2):309–21. doi: 10.1681/ASN.2022070818. PMID: 36368777. [PMC free article: PMC10103103] [PubMed: 36368777] [CrossRef]

Doshi MD, Schaubel DE, Xu Y, et al Clinical utility in adopting race-free kidney donor risk index. Transplant Direct. 2022 Jul;8(7):e1343. doi: 10.1097/TXD.0000000000001343. PMID: 35747522. [PMC free article: PMC9208880] [PubMed: 35747522] [CrossRef]

Drawz PE, Baraniuk S, Davis BR, et al Cardiovascular risk assessment: addition of CKD and race to the Framingham equation. Am Heart J. 2012 Dec;164(6):925–31.e2. doi: 10.1016/j.ahj.2012.09.003. PMID: 23194494. [PMC free article: PMC3511773] [PubMed: 23194494] [CrossRef]

Duggal V, Thomas IC, Montez-Rath ME, et al National estimates of CKD prevalence and potential impact of estimating glomerular filtration rate without race. J Am Soc Nephrol. 2021 Jun;32(6):1454–63. doi: 10.1681/ASN.2020121780. PMID: 33958490. [PMC free article: PMC8259653] [PubMed: 33958490] [CrossRef]

Elmaleh-Sachs A, Balte P, Oelsner EC, et al Race/ethnicity, spirometry reference equations and prediction of incident clinical events: the multi-ethnic study of atherosclerosis (MESA) lung study. Am J Respir Crit Care Med. 2022 Mar;205(6):700–10. doi: 10.1164/rccm.202107-1612OC. PMID: 34913853. [PubMed: 34913853] [CrossRef]

Fairman KA, Romanet D, Early NK, et al Estimated cardiovascular risk and guideline-concordant primary prevention with statins: retrospective cross-sectional analyses of US ambulatory visits using competing algorithms. J Cardiovasc Pharmacol Ther. 2020 Jan;25(1):27–36. doi: 10.1177/1074248419866153. PMID: 31353942. [PubMed: 31353942] [CrossRef]

Foryciarz A, Pfohl SR, Patel B, et al Evaluating algorithmic fairness in the presence of clinical guidelines: the case of atherosclerotic cardiovascular disease risk estimation. BMJ Health Care Inform. 2022 Apr;29(1):e100460. doi: 10.1136/bmjhci-2021-100460. PMID: 35396247. [PMC free article: PMC8996004] [PubMed: 35396247] [CrossRef]

Fox ER, Samdarshi TE, Musani SK, et al Development and validation of risk prediction models for cardiovascular events in black adults: the Jackson heart study cohort. JAMA Cardiol. 2016 Apr;1(1):15–25. doi: 10.1001/jamacardio.2015.0300. PMID: 27437649. [PMC free article: PMC5115626] [PubMed: 27437649] [CrossRef]

Gutiérrez OM, Sang Y, Grams ME, et al Association of estimated GFR calculated using race-free equations with kidney failure and mortality by black vs non-black race. JAMA. 2022 Jun;327(23):2306–16. doi: 10.1001/jama.2022.8801. PMID: 35667006. [PMC free article: PMC9171658] [PubMed: 35667006] [CrossRef]

Hammond G, Johnston K, Huang K, et al Social determinants of health improve predictive accuracy of clinical risk models for cardiovascular hospitalization, annual cost, and death. Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006752. doi: 10.1161/CIRCOUTCOMES.120.006752. PMID: 32412300. [PMC free article: PMC7299736] [PubMed: 32412300] [CrossRef]

Hoenig MP, Mann A, Pavlakis M. Removal of the Black race coefficient from the estimated glomerular filtration equation improves transplant eligibility for Black patients at a single center. Clin Transplant. 2022 Feb;36(2):e14467. doi: 10.1111/ctr.14467. PMID: 34605076. [PubMed: 34605076] [CrossRef]

Huang C, Murugiah K, Li X, et al Effect of removing race correction factor in glomerular filtration rate estimation on predicting acute kidney injury after percutaneous coronary intervention. medRxiv. 2022 Jan. doi: 10.1101/2022.01.18.22269155. [PMC free article: PMC10622038] [PubMed: 37009734] [CrossRef]

Inker LA, Couture SJ, Tighiouart H, et al A new panel-estimated GFR, including ß(2)-microglobulin and ß-trace protein and not including race, developed in a diverse population. Am J Kidney Dis. 2021 Nov;77(5):673–83.e1. doi: 10.1053/j.ajkd.2020.11.005. PMID: 33301877. [PMC free article: PMC8102017] [PubMed: 33301877] [CrossRef]

Inker LA, Eneanya ND, Coresh J, et al New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021 Nov;385(19):1737–49. doi: 10.1056/NEJMoa2102953. PMID: 34554658. [PMC free article: PMC8822996] [PubMed: 34554658] [CrossRef]

Julian BA, Gaston RS, Brown WM, et al Effect of replacing race with apolipoprotein L1 genotype in calculation of kidney donor risk index. Am J Transplant. 2017 Jun;17(6):1540–8. doi: 10.1111/ajt.14113. PMID: 27862962. [PMC free article: PMC5429996] [PubMed: 27862962] [CrossRef]

Kabra R, Girotra S, Vaughan Sarrazin M. Refining stroke prediction in atrial fibrillation patients by addition of African-American ethnicity to CHA(2)DS(2)-VASc score. J Am Coll Cardiol. 2016 Aug;68(5):461–70. doi: 10.1016/j.jacc.2016.05.044. PMID: 27470453. [PMC free article: PMC5394427] [PubMed: 27470453] [CrossRef]

Kimmel SE, French B, Kasner SE, et al A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 2013;369(24):2283–93. doi: 10.1056/NEJMoa1310669. PMID: 24251361. [PMC free article: PMC3942158] [PubMed: 24251361] [CrossRef]

Landy R, Young CD, Skarzynski M, et al Using prediction-models to reduce persistent racial/ethnic disparities in draft 2020 USPSTF lung-cancer screening guidelines. J Natl Cancer Inst. 2021 Nov;113(11):1590–4. doi: 10.1093/jnci/djaa211. PMID: 33399825. [PMC free article: PMC8562965] [PubMed: 33399825] [CrossRef]

Limdi NA, Brown TM, Yan Q, et al Race influences warfarin dose changes associated with genetic factors. Blood. 2015 Jul;126(4):539–45. doi: 10.1182/blood-2015-02-627042. PMID: 26024874. [PMC free article: PMC4513254] [PubMed: 26024874] [CrossRef]

Lindley KJ, Limdi NA, Cavallari LH, et al Warfarin dosing in patients with CYP2C9*5 variant alleles. Clin Pharmacol Ther. 2022;111(4):950–5. doi: 10.1002/cpt.2549. PMID: 35108398. [PubMed: 35108398] [CrossRef]

Mahmud N, Asrani SK, Reese PP, et al Race adjustment in eGFR equations does not improve estimation of acute kidney injury events in patients with cirrhosis. Dig Dis Sc. 2022 Apr;67(4):1399–408. doi: 10.1007/s10620-021-06943-1. PMID: 33761091. [PMC free article: PMC8460692] [PubMed: 33761091] [CrossRef]

Meeusen JW, Kasozi RN, Larson TS, et al Clinical impact of the refit CKD-EPI 2021 creatinine-based eGFR equation. Clin Chem. 2022;68(4):534–9. doi: 10.1093/clinchem/hvab282. PMID: 35038721. [PubMed: 35038721] [CrossRef]

Miller J, Lyden GR, McKinney WT, et al Impacts of removing race from the calculation of the kidney donor profile index. Am J Transplant. 2023 May;23(5):636–41. doi: 10.1016/j.ajt.2022.12.016. PMID: 36695678. [PubMed: 36695678] [CrossRef]

Miller J, Knorr JP. Impact of removing the race coefficient in renal function estimate equations on drug dosage recommendations. Ann Pharmacother. 2022 Jan;56(1):44–51. doi: 10.1177/10600280211010228. PMID: 33866823. [PubMed: 33866823] [CrossRef]

Muiru AN, Madden E, Scherzer R, et al Effect of adopting the new race-free 2021 chronic kidney disease epidemiology collaboration estimated glomerular filtration rate creatinine equation on racial differences in kidney disease progression among people with human immunodeficiency virus: an observational study. Clin Infect Dis. 2023 Feb;76(3):461–8. doi: 10.1093/cid/ciac731. PMID: 36069064. [PMC free article: PMC10169400] [PubMed: 36069064] [CrossRef]

Panchal S, Serper M, Bittermann T, et al Impact of race-adjusted glomerular filtration rate estimation on eligibility for simultaneous liver-kidney transplantation. Liver Transpl. 2022 Jun;28(6):959–68. doi: 10.1002/lt.26310. PMID: 34558791. [PMC free article: PMC8943444] [PubMed: 34558791] [CrossRef]

Park Y, Hu J, Singh M, et al Comparison of methods to reduce bias from clinical prediction models of postpartum depression. JAMA Netw Open. 2021 Apr;4(4):e213909. doi: 10.1001/jamanetworkopen.2021.3909. PMID: 33856478. [PMC free article: PMC8050742] [PubMed: 33856478] [CrossRef]

Schmeusser BN, Palacios AR, Midenberg ER, et al Race-free renal function estimation equations and potential impact on Black patients: implications for cancer clinical trial enrollment. Cancer. 2023 Mar;129(6):920–4. doi: 10.1002/cncr.34637. PMID: 36606692. [PubMed: 36606692] [CrossRef]

Shi J, Lindo EG, Baird GS, et al Calculating estimated glomerular filtration rate without the race correction factor: observations at a large academic medical system. Clin Chim Acta. 2021 Sep;520:16–22. doi: 10.1016/j.cca.2021.05.022. PMID: 34052206. [PMC free article: PMC8286343] [PubMed: 34052206] [CrossRef]

Shores NJ, Dodge JL, Feng S, et al Donor risk index for African American liver transplant recipients with hepatitis C virus. Hepatology. 2013 Oct;58(4):1263–9. doi: 10.1002/hep.26478. PMID: 23696235. [PMC free article: PMC4561529] [PubMed: 23696235] [CrossRef]

Topel ML, Shen J, Morris AA, et al Comparisons of the Framingham and pooled cohort equation risk scores for detecting subclinical vascular disease in Blacks versus whites. Am J Cardiol. 2018 Mar;121(5):564–9. doi: 10.1016/j.amjcard.2017.11.031. PMID: 29361288. [PMC free article: PMC5905433] [PubMed: 29361288] [CrossRef]

Tsai JW, Cerdeña JP, Goedel WC, et al Evaluating the impact and rationale of race-specific estimations of kidney function: estimations from U.S. NHANES, 2015–2018. EClinicalMedicine. 2021 Dec;42:101197. doi: 10.1016/j.eclinm.2021.101197. PMID: 34849475. [PMC free article: PMC8608882] [PubMed: 34849475] [CrossRef]

Weale ME, Riveros-Mckay F, Selzam S, et al Validation of an integrated risk tool, including polygenic risk score, for atherosclerotic cardiovascular disease in multiple ethnicities and ancestries. Am J Cardiol. 2021 Jun;148:157–64. doi: 10.1016/j.amjcard.2021.02.032. PMID: 33675770. [PubMed: 33675770] [CrossRef]

Yadlowsky S, Hayward RA, Sussman JB, et al Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann Intern Med. 2018 Jul;169(1):20–9. doi: 10.7326/M17-3011. PMID: 29868850. [PubMed: 29868850] [CrossRef]

Yap E, Prysyazhnyuk Y, Ouyang J, et al The implication of dropping race from the MDRD equation to estimate GFR in an African American-only cohort. Int J Nephrol. 2021 Nov;2021:1880499. doi: 10.1155/2021/1880499. PMID: 34824870. [PMC free article: PMC8610663] [PubMed: 34824870] [CrossRef]

Zelnick LR, Leca N, Young B, et al Association of the estimated glomerular filtration rate with vs without a coefficient for race with time to eligibility for kidney transplant. JAMA Netw Open. 2021 Jan;4(1):e2034004. doi: 10.1001/jamanetworkopen.2020.34004. PMID: 33443583. [PMC free article: PMC7809586] [PubMed: 33443583] [CrossRef]

Pasquinelli MM, Tammemägi MC, Kovitz KL, et al Risk prediction model versus United States Preventive Services Task Force lung cancer screening eligibility criteria: reducing race disparities. J Thorac Oncol. 2020 Nov;15(11):1738–47. doi: 10.1016/j.jtho.2020.08.006. PMID: 32822843. [PubMed: 32822843] [CrossRef]

Peterson PN, Rumsfeld JS, Liang L, et al A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):25–32. doi: 10.1161/circoutcomes.109.854877. PMID: 20123668. [PubMed: 20123668] [CrossRef]

Obi Y, Nguyen DV, Zhou H, et al Development and validation of prediction scores for early mortality at transition to dialysis. Mayo Clin Proc. 2018 Sep;93(9):1224–35. doi: 10.1016/j.mayocp.2018.04.017. PMID: 30104041. [PubMed: 30104041] [CrossRef]

O'Brien SM, Feng L, He X, et al The Society of Thoracic Surgeons 2018 adult cardiac surgery risk models: part 2-statistical methods and results. Ann Thorac Surg. 2018 May;105(5):1419–28. doi: 10.1016/j.athoracsur.2018.03.003. PMID: 29577924. [PubMed: 29577924] [CrossRef]

Shahian DM, Jacobs JP, Badhwar V, et al The Society of Thoracic Surgeons 2018 adult cardiac surgery risk models: part 1-background, design considerations, and model development. Ann Thorac Surg. 2018 May;105(5):1411–8. doi: 10.1016/j.athoracsur.2018.03.002. PMID: 29577925. [PubMed: 29577925] [CrossRef]

Haukoos JS, Lyons MS, Lindsell CJ, et al Derivation and validation of the Denver human immunodeficiency virus (HIV) risk score for targeted HIV screening. Am J Epidemiol. 2012 Apr;175(8):838–46. doi: 10.1093/aje/kwr389. PMID: 22431561. [PMC free article: PMC3390011] [PubMed: 22431561] [CrossRef]

Haukoos JS, Hopkins E, Bucossi MM, et al Brief report: validation of a quantitative HIV risk prediction tool using a national HIV testing cohort. J Acquir Immune Defic Syndr. 2015 Apr;68(5):599–603. doi: 10.1097/QAI.0000000000000518. PMID: 25585300. [PMC free article: PMC4357562] [PubMed: 25585300] [CrossRef]

Haukoos JS, Lyons MS, Rothman RE, et al Comparison of HIV screening strategies in the emergency department: a randomized clinical trial. JAMA Netw Open. 2021 Jul;4(7):e2117763. doi: 10.1001/jamanetworkopen.2021.17763. PMID: 34309668. [PMC free article: PMC8314142] [PubMed: 34309668] [CrossRef]

Dunlevy H, Robins M, Ashwood E, et al Targeted HIV-testing in the emergency department with linkage to care using an HIV risk score. Aurora (CO): 2018 National Ryan White Conference on HIV Care & Treatment; 2018. https://targethiv​.org​/sites/default/files​/supporting-files/11016_Dunlevy_508.pdf. Accessed on August 1, 2022.